以血管为导向的淋巴结清扫术在腹腔镜远端胃癌D2根治术中的应用价值

Application value of vessel-guided lymph node dissection in the laparoscopic radical gastrectomy (D2) of distal gastric cancer

  • 摘要: 目的:探讨以血管为导向的淋巴结清扫术在腹腔镜远端胃癌D2根治术中的应用价值。
    方法:采用回顾性横断面研究方法。收集2012年10月至2015年7月山西医科大学附属肿瘤医院收治的157例行腹腔镜远端胃癌D2根治术患者的临床病理资料。采用以血管为导向的淋巴结清扫术,分为以结肠中血管为导向的幽门下区淋巴结清扫术、以胃十二指肠动脉为导向的幽门上区淋巴结清扫术、以肝总动脉为导向的胰腺右上缘淋巴结清扫术、以脾动脉为导向的胰腺左上缘淋巴结清扫术4个步骤。观察指标:(1)手术及术中情况。(2)术后病理学检查情况。(3)随访情况。采用门诊和电话方式进行随访,了解患者术后3年生存率。随访时间截至2017年6月。正态分布的计量资料以±s表示。采用Kaplan-Meier法计算生存率。
    结果:(1)手术及术中情况:157例患者均成功完成腹腔镜远端胃癌D2根治术,手术时间为(178±38)min,淋巴结清扫时间为(61±27)min,术中出血量为(87±40)mL,术后首次下床活动时间为(1.2±0.4)d,术后肛门首次排气时间为(2.8±1.3)d,术后腹腔引流管拔除时间为(7.5±2.6)d。157例患者中,10例发生术后并发症,其中5例肠梗阻、3例吻合口瘘均经保守治疗后好转,2例老年患者因肺部感染死亡;其余患者未发生并发症。157例患者术后住院时间为(9±3)d。(2)术后病理学检查情况:157例患者淋巴结清扫总数为(34.6±11.0)枚,幽门下区淋巴结清扫数目为(4.8±2.1)枚,胰腺上缘淋巴结清扫数目为(12.3±4.7)枚;肿瘤TNM分期:Ⅰa期26例,Ⅰb期33例,Ⅱa期18例,Ⅱb期24例,Ⅲa期37例,Ⅲb期19例。(3)随访情况: 157例患者中,142例获得术后随访,随访时间为6~56个月,中位随访时间为27个月,术后3年生存率为67.6%。
    结论:以血管为导向的淋巴结清扫术应用于腹腔镜远端胃癌D2根治术中安全有效,可简化手术步骤。

     

    Abstract: Objective:To investigate the application value of vessel-guided lymph node dissection (LND) in the laparoscopic distal gastrectomy (D2) of distal gastric cancer.
    Methods:The retrospective cross-sectional study was conducted. The clinicopathological data of 157 patients who underwent laparoscopic distal gastrectomy (D2) of distal gastric cancer in the Affiliated Tumor Hospital of Shanxi Medical University from October 2012 to July 2015 were collected. Patients used vessel-guided LND that was divided into 4 steps: middle colic vessel-guided LND in the upper pyloric region, gastroduodenal artery-guided LND in the lower pyloric region, common hepatic artery-guided LND in the right upper margin of pancreas and splenic artery-guided LND in the left upper margin of pancreas. Observation indicators: (1) surgical and intraoperative situations, (2) postoperative pathological results, (3) follow-up situations. Follow-up using outpatient examination and telephone interview was performed to detect the postoperative 3-year survival rate up to June 2017. Measurement data with normal distribution were represented as ±s. The survival rate was calculated using the Kaplan-Meier method.
    Results: (1) Surgical and intraoperative situations: 157 patients underwent successful laparoscopic distal gastrectomy (D2) of distal gastric cancer. Operation time, LND time, volume of intraoperative blood loss, time for initial out-of-bed activity, time to initial anal exsufflation and time of postoperative abdominal drainage-tube removal were (178±38)minutes, (61±27)minutes, (87±40)mL, (1.2±0.4)days, (2.8±1.3)days and (7.5±2.6)days, respectively. Of 157 patients, 10 with postoperative complications were improved by conservative treatment, including 5 with intestinal obstruction, 3 with anastomotic fistula and 2 dying of pulmonary infection; other patients didn′t have complications. Duration of hospital stay of 157 patients was (9±3)days. (2) Postoperative pathological results: total number of LND, numbers of LND in the lower pyloric region and in the upper margin of pancreas were 34.6±11.0, 4.8±2.1 and 12.3±4.7, respectively. TNM staging: 26, 33, 18, 24, 37 and 19 patients were respectively detected in stageⅠa, Ⅰb, Ⅱa, Ⅱb, Ⅲa and Ⅲb. (3) Follow-up situations: 142 of 157 patients were followed up for 6-56 months, with a median time of 27 months, and postoperative 3-year survival rate was 67.6%.
    Conclusion:The vessel-guided LND is safe and effective in the laparoscopic distal gastrectomy (D2) of distal gastric cancer, and the operation steps can be simplified.

     

/

返回文章
返回